日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Benchmarking mouse contamination removing protocols in patient-derived xenografts genomic profiling

对患者来源异种移植基因组分析中去除小鼠污染的方案进行基准测试

Bhandari, Mukund; He, Funan; Rogojina, Anna; Li, Fuyang; Zou, Yi; Jiang, Jing; Lai, Zhao; Houghton, Peter; Kurmasheva, Raushan T; Chen, Yidong; Wang, Xiaojing; Zheng, Siyuan

Lessons learned from 20 years of preclinical testing in pediatric cancers

从20年的儿科癌症临床前试验中汲取的经验教训

Smith, Malcolm A; Houghton, Peter J; Lock, Richard B; Maris, John M; Gorlick, Richard; Kurmasheva, Raushan T; Li, Xiao-Nan; Teicher, Beverly A; Chuang, Jeffrey H; Dela Cruz, Filemon S; Dyer, Michael A; Kung, Andrew L; Lloyd, Michael W; Mossé, Yael P; Stearns, Timothy M; Stewart, Elizabeth A; Bult, Carol J; Erickson, Stephen W

Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma

表面和整体蛋白质组分析确定 ENPP1 和其他表面蛋白是尤文氏肉瘤的可操作免疫治疗靶点

Brian Mooney, Gian Luca Negri, Taras Shyp, Alberto Delaidelli, Hai-Feng Zhang, Sandra E Spencer Miko, Amber K Weiner, Alexander B Radaoui, Rawan Shraim, Michael M Lizardo, Christopher S Hughes, Amy Li, Amal M El-Naggar, Melanie Rouleau, Wei Li, Dimiter S Dimitrov, Raushan T Kurmasheva, Peter J Hough

Synergistic Antitumor Activity of Talazoparib and Temozolomide in Malignant Rhabdoid Tumors

他拉唑帕尼与替莫唑胺在恶性横纹肌瘤中的协同抗肿瘤活性

Elena Mironova, Sebastian Molinas, Vanessa Del Pozo, Abhik M Bandyopadhyay, Zhao Lai, Dias Kurmashev, Eric L Schneider, Daniel V Santi, Yidong Chen, Raushan T Kurmasheva

Comprehensive characterization of patient-derived xenograft models of pediatric leukemia

对儿童白血病患者来源异种移植模型进行全面表征

Anna Rogojina ,Laura J Klesse ,Erin Butler ,Jiwoong Kim ,He Zhang ,Xue Xiao ,Lei Guo ,Qinbo Zhou ,Taylor Hartshorne ,Dawn Garcia ,Korri Weldon ,Trevor Holland ,Abhik Bandyopadhyay ,Luz Perez Prado ,Shidan Wang ,Donghan M Yang ,Anne-Marie Langevan ,Yi Zou ,Allison C Grimes ,Chatchawin Assanasen ,Vinod Gidvani-Diaz ,Siyuan Zheng ,Zhao Lai ,Yidong Chen ,Yang Xie ,Gail E Tomlinson ,Stephen X Skapek ,Raushan T Kurmasheva ,Peter J Houghton ,Lin Xu

PARP1-MGMT complex underpins pathway crosstalk in O(6)-methylguanine repair

PARP1-MGMT复合物在O(6)-甲基鸟嘌呤修复过程中发挥通路串扰的作用

Cropper, Jodie D; Alimbetov, Dauren S; Brown, Kevin T G; Likhotvorik, Rostislav I; Robles, Andrew J; Guerra, James T; He, Boxue; Chen, Yidong; Kwon, Youngho; Kurmasheva, Raushan T

Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models

MAPK 信号对 TORC1 的调节决定了儿童 BRAFV600E 脑肿瘤模型对曲美替尼的敏感性和获得性耐药性

Fuyang Li, Kathryn M Bondra, Samson Ghilu, Adam Studebaker, Qianqian Liu, Joel E Michalek, Mari Kogiso, Xiao-Nan Li, John A Kalapurakal, C David James, Sandeep Burma, Raushan T Kurmasheva, Peter J Houghton

Extrarenal Anaplastic Wilms Tumor: A Case Report With Genomic Analysis and Tumor Models

肾外间变性肾母细胞瘤:病例报告、基因组分析及肿瘤模型

Willis, Kelsi R; Sathe, Adwait A; Xing, Chao; Koduru, Prasad; Artunduaga, Maddy; Butler, Erin B; Park, Jason Y; Kurmasheva, Raushan T; Houghton, Peter J; Chen, Kenneth S; Rakheja, Dinesh

PEGylated talazoparib enhances therapeutic window of its combination with temozolomide in Ewing sarcoma

聚乙二醇化他拉唑帕尼可增强其与替莫唑胺联合治疗尤文氏肉瘤的治疗窗口

Vanessa Del Pozo ,Andrew J Robles ,Shaun D Fontaine ,Qianqian Liu ,Joel E Michalek ,Peter J Houghton ,Raushan T Kurmasheva

In vivo evaluation of the EZH2 inhibitor (EPZ011989) alone or in combination with standard of care cytotoxic agents against pediatric malignant rhabdoid tumor preclinical models-A report from the Pediatric Preclinical Testing Consortium

EZH2抑制剂(EPZ011989)单独或与标准治疗细胞毒性药物联合用于儿童恶性横纹肌样瘤临床前模型的体内评估——儿科临床前试验联盟的报告

Kurmasheva, Raushan T; Erickson, Stephen W; Earley, Eric; Smith, Malcolm A; Houghton, Peter J